
### [NCIT:C3867](http://purl.obolibrary.org/obo/NCIT_C3867)
**Label:** Fallopian Tube Carcinoma

**Subclasses:** [NCIT:C115429](http://purl.obolibrary.org/obo/NCIT_C115429) (Recurrent Fallopian Tube Carcinoma), [NCIT:C6265](http://purl.obolibrary.org/obo/NCIT_C6265) (Fallopian Tube Adenocarcinoma), [NCIT:C6279](http://purl.obolibrary.org/obo/NCIT_C6279) (Fallopian Tube Endometrioid Adenocarcinoma), [NCIT:C6278](http://purl.obolibrary.org/obo/NCIT_C6278) (Fallopian Tube Gestational Choriocarcinoma), [NCIT:C6267](http://purl.obolibrary.org/obo/NCIT_C6267) (Fallopian Tube Papillary Adenocarcinoma), [NCIT:C40104](http://purl.obolibrary.org/obo/NCIT_C40104) (Fallopian Tube Transitional Cell Carcinoma), [NCIT:C40105](http://purl.obolibrary.org/obo/NCIT_C40105) (Stage 0 Fallopian Tube Cancer), [NCIT:C6280](http://purl.obolibrary.org/obo/NCIT_C6280) (Fallopian Tube Clear Cell Adenocarcinoma), [NCIT:C126449](http://purl.obolibrary.org/obo/NCIT_C126449) (Serous Tubal Intraepithelial Carcinoma), [NCIT:C40455](http://purl.obolibrary.org/obo/NCIT_C40455) (Hereditary Fallopian Tube Carcinoma), [NCIT:C40103](http://purl.obolibrary.org/obo/NCIT_C40103) (Fallopian Tube Mucinous Adenocarcinoma), [NCIT:C6282](http://purl.obolibrary.org/obo/NCIT_C6282) (Fallopian Tube Squamous Cell Carcinoma), [NCIT:C6281](http://purl.obolibrary.org/obo/NCIT_C6281) (Undifferentiated Fallopian Tube Carcinoma), [NCIT:C126456](http://purl.obolibrary.org/obo/NCIT_C126456) (High Grade Fallopian Tube Serous Adenocarcinoma), [NCIT:C40099](http://purl.obolibrary.org/obo/NCIT_C40099) (Fallopian Tube Serous Adenocarcinoma), [NCIT:C126457](http://purl.obolibrary.org/obo/NCIT_C126457) (Low Grade Fallopian Tube Serous Adenocarcinoma), 

**Class expressions from DL-Learner:**

- [UBERON:0000474](http://purl.obolibrary.org/obo/UBERON_0000474) (female reproductive system) 75.00%
- [UBERON:0003889](http://purl.obolibrary.org/obo/UBERON_0003889) (fallopian tube) 53.87%
- [UBERON:0000990](http://purl.obolibrary.org/obo/UBERON_0000990) (reproductive system) 53.87%
- [UBERON:0000061](http://purl.obolibrary.org/obo/UBERON_0000061) (anatomical structure) 51.81%
- [UBERON:0000465](http://purl.obolibrary.org/obo/UBERON_0000465) (material anatomical entity) 51.70%
- [UBERON:0001062](http://purl.obolibrary.org/obo/UBERON_0001062) (anatomical entity) 51.60%
- [BFO:0000040](http://purl.obolibrary.org/obo/BFO_0000040) (material entity) 51.59%
- [BFO:0000004](http://purl.obolibrary.org/obo/BFO_0000004) (null) 51.45%
- [BFO:0000002](http://purl.obolibrary.org/obo/BFO_0000002) (null) 51.44%
- Thing 50.92%
- [UBERON:0000467](http://purl.obolibrary.org/obo/UBERON_0000467) (anatomical system) 32.81%
- [UBERON:0015212](http://purl.obolibrary.org/obo/UBERON_0015212) (lateral structure) 31.25%
- [UBERON:0000064](http://purl.obolibrary.org/obo/UBERON_0000064) (organ part) 27.65%
- [UBERON:0004120](http://purl.obolibrary.org/obo/UBERON_0004120) (mesoderm-derived structure) 27.53%
- [UBERON:0010000](http://purl.obolibrary.org/obo/UBERON_0010000) (multicellular anatomical structure) 26.31%


